FDA inspection
Novartis Pharma Stein AG: FDA inspection ending May 19, 2026
FDA inspection 1319902 · Voluntary Action Indicated (VAI) · Stein Ag
Key facts
| Inspection ID | 1319902 |
|---|---|
| Firm | Novartis Pharma Stein AG |
| FEI number | 3002653483 |
| Address | Schaffhauserstrasse 101 |
| City | Stein Ag |
| Country | Switzerland |
| Fiscal year | 2026 |
| Inspection end date | May 19, 2026 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Human Cellular, Tissue, and Gene Therapies |
| Product type | Biologics |
At a glance
- 1–9 Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 10–99 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data